Mark Denison MD
Professor, Pediatrics, Vanderbilt University School of Medicine
Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-3000
Dr. Denison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am the Stahlman Chair and Professor of Pediatrics, and Professor of Pathology, Microbiology & Immunology at Vanderbilt University School of Medicine. I am a Pediatric Infectious Disease Specialist and Perform Research on Emerging Infectious Diseases, Specifically the coronaviruses including SARS-CoV, MERS-CoV, and the novel Coronavirus nCoV-19 / COVID-19 / SARS-CoV-2. I have studied the replication, pathogenesis and evolution of coronaviruses and have developed antivirals against SARS-CoV-2.
Education & Training
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 1980 - 1986
University of Kansas School of MedicineClass of 1980
Certifications & Licensure
TN State Medical License 1991 - 2025
OR State Medical License 2002 - 2002
PA State Medical License 1987 - 1992
IA State Medical License 1980 - 1987
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Edward Claiborne Stahlman Chair in Pediatric Physiology and Cell Metabolism Vanderbilt University
- Distinguished Medical Alumnus Kansas University School of Medicine, 2020
- Fellow Association of American Physicians, 2016
- Join now to see all
Publications & Presentations
PubMed
- The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity.Samantha L Grimes, Brook E Heaton, Mackenzie L Anderson, Katie Burke, Laura Stevens
Journal of Virology. 2025-02-25 - MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies.Olubukola M Abiona, Nianshuang Wang, Sarah R Leist, Alexandra Schäfer, Adam S Cockrell
Iscience. 2025-02-21 - 1 citationsAn oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo.Nian E Zhou, Su Tang, Xuelin Bian, Maloy K Parai, Inna V Krieger
Cell Reports. 2024-11-26
Press Mentions
Can Carrot Juice Give You a ‘Natural Tan’?; Lorazepam Use on ‘White Lotus’; Dangers of the Flu for Children; Plus Other News Stories with VUMC SourcesMarch 13th, 2025
COVID-19 Pandemic at 5: Will Funding Cuts Hinder Our Future Preparedness?March 11th, 2025
Eleven Vanderbilt Scientists Among World’s “Highly Cited” ResearchersNovember 19th, 2024- Join now to see all
Grant Support
- Determinants of Coronavirus Replication FidelityNIH, NIAID2013–2023
- Cell Biology of Coronavirus InfectionNIH, NIAIDPresent
- Polymerase Proteins in Coronavirus ReplicationNIH, NIAIDPresent
Professional Memberships
- Fellow
- American Society for VirologyMember
- American Society for MicrobiologyMember
- Pediatric Infectious Diseases SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
